Skip to content

Paula Brady, M.D.

NPI 1194024877ActiveIndividual· Obstetrics & Gynecology, Reproductive Endocrinology· New York, NY

Obstetrics & Gynecology, Reproductive Endocrinology (M.D.) in New York, New York, licensed in NY, with an NPI issued in March 2011. Enrolled in Medicare as order and referring only - obstetrics/gynecology. Ferring Pharmaceuticals Inc. reported $12,314 in payments in 2025, mostly consulting fees.

Overview

NPI1194024877
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedMar 21, 2011
Last updated in NPPESMar 20, 2023
Certified by providerMar 20, 2023

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Obstetrics/Gynecology (MA)

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$12,314 · 15 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Ferring Pharmaceuticals Inc.$12,31415

What the 2025 payments were for

  • Consulting Fee$10,503 · 1 payment
  • Travel and Lodging$1,412 · 7 payments
  • Food and Beverage$398.55 · 7 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Obstetrics & Gynecology, Reproductive Endocrinology providers in New York

All 153 Obstetrics & Gynecology, Reproductive Endocrinology providers in New York · All Obstetrics & Gynecology, Reproductive Endocrinology providers in New York